World Vaccine Congress Europe 2026 has ended. This guide stays up as the record of who was there. Next: WVC Europe 2027, Oct 25–27, 2027 in Lyon
CHO Pharma at World Vaccine Congress Europe 2026
Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website
CHO Pharma takes part in 1 session at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits. Its program centres on its K1/K2 glycoconjugate vaccine against hypervirulent, meaning especially aggressive, Klebsiella pneumoniae bacteria. It shares early safety results, and early data on whether the immune responses the vaccine triggers actually work, from its first trial in people.
| Organization | World Vaccine Congress Europe 2026 Attendance |
|---|---|
CP CHO Pharma | |
Develops glycoconjugate vaccines, including a K1/K2 vaccine against hypervirulent Klebsiella pneumoniae in first-in-human trials. | Booth Exhibiting (no floor booth listed) |
Find decision makers at CHO Pharma
Tell us what you sell and we’ll find the people at CHO Pharma most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction